Status:
COMPLETED
Sodium Intake in Multiple Sclerosis
Lead Sponsor:
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-50 years
Brief Summary
Recently, it has been shown that salt (ClNa, sodium chloride) can modulate the differentiation of human and mouse TH17 cells. Indeed, mice feed with high sodium diet were described to develop more agg...
Eligibility Criteria
Inclusion
- Subject is between 18 and 50 years old
- Subject has diagnosis of relapsing-remitting MS according to McDonald criteria (2010)
Exclusion
- Patient who had hyponatremia in the last 90 days
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01846234
Start Date
November 1 2010
End Date
July 1 2013
Last Update
October 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FLENI
Buenos Aires, Argentina, 1428